Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up

Stagecoach Share Price (SGC)

Show Chart Filters
Time period:
Moving Average:
Compare to:
Price 129.30on 21-08-2019 at 12:31:43
Change 1.10 0.86%
Buy 129.40
Sell 129.30
Buy / Sell SGC Shares
Sponsored Financial Content
Last Trade: Sell 367 at 129.30p
Day's Volume: 277,693
Last Close: 128.20p
Open: 126.60p
Day's Range 126.60p - 130.20p
52wk Range: 113.60p - 184.70p
Market Capitalisation: £719m
VWAP: 129.426p
Shares in Issue: 556m

Recent Trades History Stagecoach (SGC)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell*367129.30Automatic Execution
12:30:51 - 21-Aug-19
Buy*226129.30Automatic Execution
12:30:51 - 21-Aug-19
12:30:06 - 21-Aug-19
Buy*26129.50Automatic Execution
12:28:33 - 21-Aug-19
Buy*1,500129.50Automatic Execution
12:28:33 - 21-Aug-19
Buy*2,511129.30Automatic Execution
12:26:09 - 21-Aug-19
Buy*225129.20Automatic Execution
12:26:09 - 21-Aug-19
Buy*296129.20Automatic Execution
12:26:09 - 21-Aug-19
Buy*2,504129.20Automatic Execution
12:26:09 - 21-Aug-19
12:23:35 - 21-Aug-19

Share Price History for Stagecoach

Time period:
Date Open High Low Close
19th Aug 2019 (Mon)125.40131.10125.40129.15
16th Aug 2019 (Fri)128.90128.90125.30128.65
15th Aug 2019 (Thu)129.80129.80126.20127.30
14th Aug 2019 (Wed)128.40128.70125.80126.65
13th Aug 2019 (Tue)128.60130.10125.90128.80
12th Aug 2019 (Mon)129.60130.10127.10128.05
9th Aug 2019 (Fri)126.70131.40126.70128.35
8th Aug 2019 (Thu)131.90131.90128.70129.90
7th Aug 2019 (Wed)129.90130.30127.90129.80
6th Aug 2019 (Tue)127.70133.00127.70129.00
5th Aug 2019 (Mon)129.90131.60128.40130.50
2nd Aug 2019 (Fri)131.10133.50129.20130.45
1st Aug 2019 (Thu)129.10133.00128.80132.15
31st Jul 2019 (Wed)133.40133.40128.60130.40
30th Jul 2019 (Tue)130.50132.70129.60130.85
29th Jul 2019 (Mon)135.70138.60133.50133.75
26th Jul 2019 (Fri)133.10135.50132.40134.45
25th Jul 2019 (Thu)137.40139.00133.50135.35
24th Jul 2019 (Wed)141.80141.80135.70136.35
23rd Jul 2019 (Tue)139.20140.60137.50138.80
22nd Jul 2019 (Mon)136.60139.90135.20137.85

SGC - Stagecoach Investor Summary

This company is currently the market leader in 'green' travel and has operations throughout the UK, North America and Canada. It has spent the last few years using innovative technologies and smart investments to steer the growth of the company and is now dedicated to improving the environmental impact that public transport has. Since 2007 Stagecoach Group PLC has developed the first bio-buses that run exclusively on bio-diesel, the first carbon neutral bus network and a number of state-of-the-art energy efficient facilities and waste recycling sites. Not bad from a company that only started 28 years ago with just two buses.

Currently the Stagecoach Group operate successful bus, rail and tram services in the UK and a leading long distance coach service in North America and Canada. Their buses run in over 100 towns and cities throughout the UK and are estimated to own a 14% share of the UK bus market. Their rail operations include South Western Trains and East Midland Trains whilst their tram services include the Sheffield Supertram and the Manchester Metrolink. In total, the company now have around 25% of the UK rail market and because of a partnership with Virgin trains and the West Coast line this is set to grow further. The Stagecoach Group believe that complimentary acquisitions help to safeguard their share price and maximise their shareholders' profits so the company regularly buy what they see to be potential growth opportunities within the UK and occasionally throughout the world.

News about Stagecoach (SGC)

Stagecoach Shares Rise on Potential US Sale

News - Wednesday, December 05, 2018

Shares in the train and bus operator Stagecoach have increased after the news broke that the company is considering selling off its struggling North American companies, including its ownership of the budget coach company Megabus....

FTSE Boosted By AstraZeneca

News - Sunday, May 14, 2017

The FTSE 100 ended the week on a high note, benefiting from a strong performance by AstraZeneca after the drug company reported that its recent trial of a cancer drug had showed promising results. The company was trialling an immunotherapy drug called Imfinzi, which it had found could lower the risk of stage III lung cancer worsening or becoming fatal....

FTSE 100 Latest

Login to your account

Forgot Password?

Not Registered